Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHP Dimetapp, Robitussin PPA Withdrawals Lead To $80 Mil. Charge In 2000

This article was originally published in The Tan Sheet

Executive Summary

American Home Products recorded an $80 mil. charge in the fourth quarter due to its removal of eight Dimetapp products and one Robitussin item in response to data linking phenylpropanolamine with hemorrhagic stroke, the company said Jan. 25.

You may also be interested in...



Dimetapp Line Extensions Filling Void Of PPA Product Withdrawals

Two new Whitehall-Robins' Dimetapp formulations are debuting at the height of the cough/cold season, replacing phenylpropanolamine-containing remedies withdrawn from the market in November.

Whitehall ChapStick Overnight TV, Print Ads Break

Whitehall-Robins Healthcare's ChapStick Overnight Lip Treatment TV and print ad campaign, launched in November, carries the tag, "For smoother, softer lips overnight."

Perrigo PPA Product Withdrawal Costs Could Reach $19 Mil.

FDA's request that drug companies voluntarily withdraw phenylpropanolamine-containing cough/cold remedies and appetite suppressants from the market is expected to have no significant, long-term financial impact on two major private labelers who are now reformulating products.

Related Content

Topics

UsernamePublicRestriction

Register

PS092115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel